Antibacterial therapy--special considerations in neutropenic patients.
D000380:Agranulocytosis / Q000188:drug therapy*; D000617:Aminoglycosides / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000150:complications / Q000175:diagnosis; D002228:Carbenicillin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005334:Fever / Q000150:complications; D006801:Humans; D007938:Leukemia / Q000150:complications; D009503:Neutropenia / Q000150:complications / Q000188:drug therapy*; D011113:Polymyxins / Q000627:therapeutic use; D013982:Ticarcillin / Q000627:therapeutic use
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D011113:Polymyxins; D013982:Ticarcillin; D002228:Carbenicillin